Table of Content

1 Market Overview of Coronavirus Vaccine
1.1 Coronavirus Vaccine Market Overview
1.1.1 Coronavirus Vaccine Product Scope
1.1.2 Coronavirus Vaccine Market Status and Outlook
1.2 Global Coronavirus Vaccine Market Size Overview by Region 2018 VS 2023 VS 2033
1.3 Global Coronavirus Vaccine Market Size by Region (2018-2033)
1.4 Global Coronavirus Vaccine Historic Market Size by Region (2018-2023)
1.5 Global Coronavirus Vaccine Market Size Forecast by Region (2024-2033)
1.6 Key Regions, Coronavirus Vaccine Market Size (2018-2033)
1.6.1 North America Coronavirus Vaccine Market Size (2018-2033)
1.6.2 Europe Coronavirus Vaccine Market Size (2018-2033)
1.6.3 Asia-Pacific Coronavirus Vaccine Market Size (2018-2033)
1.6.4 Latin America Coronavirus Vaccine Market Size (2018-2033)
1.6.5 Middle East & Africa Coronavirus Vaccine Market Size (2018-2033)
2 Coronavirus Vaccine Market by Type
2.1 Introduction
2.1.1 Coronavirus Inactivated Vaccine
2.1.2 Live Attenuated Coronavirus Vaccine
2.1.3 Coronavirus Vaccine Based On S Protein
2.2 Global Coronavirus Vaccine Market Size by Type: 2018 VS 2023 VS 2033
2.2.1 Global Coronavirus Vaccine Historic Market Size by Type (2018-2023)
2.2.2 Global Coronavirus Vaccine Forecasted Market Size by Type (2024-2033)
2.3 Key Regions Market Size by Type
2.3.1 North America Coronavirus Vaccine Revenue Breakdown by Type (2018-2033)
2.3.2 Europe Coronavirus Vaccine Revenue Breakdown by Type (2018-2033)
2.3.3 Asia-Pacific Coronavirus Vaccine Revenue Breakdown by Type (2018-2033)
2.3.4 Latin America Coronavirus Vaccine Revenue Breakdown by Type (2018-2033)
2.3.5 Middle East and Africa Coronavirus Vaccine Revenue Breakdown by Type (2018-2033)
3 Coronavirus Vaccine Market Overview by Application
3.1 Introduction
3.1.1 Hospital
3.1.2 Clinic
3.1.3 Research Institute
3.1.4 Other
3.2 Global Coronavirus Vaccine Market Size by Application: 2018 VS 2023 VS 2033
3.2.1 Global Coronavirus Vaccine Historic Market Size by Application (2018-2023)
3.2.2 Global Coronavirus Vaccine Forecasted Market Size by Application (2024-2033)
3.3 Key Regions Market Size by Application
3.3.1 North America Coronavirus Vaccine Revenue Breakdown by Application (2018-2033)
3.3.2 Europe Coronavirus Vaccine Revenue Breakdown by Application (2018-2033)
3.3.3 Asia-Pacific Coronavirus Vaccine Revenue Breakdown by Application (2018-2033)
3.3.4 Latin America Coronavirus Vaccine Revenue Breakdown by Application (2018-2033)
3.3.5 Middle East and Africa Coronavirus Vaccine Revenue Breakdown by Application (2018-2033)
4 Coronavirus Vaccine Competition Analysis by Players
4.1 Global Coronavirus Vaccine Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)
4.3 Date of Key Players Enter into Coronavirus Vaccine Market
4.4 Global Top Players Coronavirus Vaccine Headquarters and Area Served
4.5 Key Players Coronavirus Vaccine Product Solution and Service
4.6 Competitive Status
4.6.1 Coronavirus Vaccine Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Іnоvіо Рhаrmасеutісаlѕ
5.1.1 Іnоvіо Рhаrmасеutісаlѕ Profile
5.1.2 Іnоvіо Рhаrmасеutісаlѕ Main Business
5.1.3 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Products, Services and Solutions
5.1.4 Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.1.5 Іnоvіо Рhаrmасеutісаlѕ Recent Developments
5.2 Моdеrnа
5.2.1 Моdеrnа Profile
5.2.2 Моdеrnа Main Business
5.2.3 Моdеrnа Coronavirus Vaccine Products, Services and Solutions
5.2.4 Моdеrnа Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.2.5 Моdеrnа Recent Developments
5.3 Nоvаvах
5.3.1 Nоvаvах Profile
5.3.2 Nоvаvах Main Business
5.3.3 Nоvаvах Coronavirus Vaccine Products, Services and Solutions
5.3.4 Nоvаvах Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.3.5 Рrоtеіn Роtеntіаl Recent Developments
5.4 Рrоtеіn Роtеntіаl
5.4.1 Рrоtеіn Роtеntіаl Profile
5.4.2 Рrоtеіn Роtеntіаl Main Business
5.4.3 Рrоtеіn Роtеntіаl Coronavirus Vaccine Products, Services and Solutions
5.4.4 Рrоtеіn Роtеntіаl Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.4.5 Рrоtеіn Роtеntіаl Recent Developments
5.5 АlрhаVах
5.5.1 АlрhаVах Profile
5.5.2 АlрhаVах Main Business
5.5.3 АlрhаVах Coronavirus Vaccine Products, Services and Solutions
5.5.4 АlрhаVах Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.5.5 АlрhаVах Recent Developments
5.6 Ѕуnаіrgеn РLС
5.6.1 Ѕуnаіrgеn РLС Profile
5.6.2 Ѕуnаіrgеn РLС Main Business
5.6.3 Ѕуnаіrgеn РLС Coronavirus Vaccine Products, Services and Solutions
5.6.4 Ѕуnаіrgеn РLС Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.6.5 Ѕуnаіrgеn РLС Recent Developments
5.7 NаnоVіrісіdеѕ
5.7.1 NаnоVіrісіdеѕ Profile
5.7.2 NаnоVіrісіdеѕ Main Business
5.7.3 NаnоVіrісіdеѕ Coronavirus Vaccine Products, Services and Solutions
5.7.4 NаnоVіrісіdеѕ Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.7.5 NаnоVіrісіdеѕ Recent Developments
5.8 GGеnеСurе
5.8.1 GGеnеСurе Profile
5.8.2 GGеnеСurе Main Business
5.8.3 GGеnеСurе Coronavirus Vaccine Products, Services and Solutions
5.8.4 GGеnеСurе Coronavirus Vaccine Revenue (US$ Million) & (2018-2023)
5.8.5 GGеnеСurе Recent Developments
6 North America
6.1 North America Coronavirus Vaccine Market Size by Country (2018-2033)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Coronavirus Vaccine Market Size by Country (2018-2033)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Coronavirus Vaccine Market Size by Region (2018-2033)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Coronavirus Vaccine Market Size by Country (2018-2033)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Coronavirus Vaccine Market Size by Country (2018-2033)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Coronavirus Vaccine Market Dynamics
11.1 Coronavirus Vaccine Industry Trends
11.2 Coronavirus Vaccine Market Drivers
11.3 Coronavirus Vaccine Market Challenges
11.4 Coronavirus Vaccine Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Coronavirus Vaccine Market Size (US$ Million) Comparison by Region 2018 VS 2023 VS 2033
Table 2. Global Coronavirus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 3. Global Coronavirus Vaccine Market Size Share by Region (2018-2023)
Table 4. Global Coronavirus Vaccine Forecasted Market Size by Region (2024-2033) & (US$ Million)
Table 5. Global Coronavirus Vaccine Forecasted Market Size Share by Region (2024-2033)
Table 6. Global Coronavirus Vaccine Market Size (US$ Million) by Type: 2018 VS 2023 VS 2033
Table 7. Global Coronavirus Vaccine Market Size by Type (2018-2023) & (US$ Million)
Table 8. Global Coronavirus Vaccine Revenue Market Share by Type (2018-2023)
Table 9. Global Coronavirus Vaccine Forecasted Market Size by Type (2024-2033) & (US$ Million)
Table 10. Global Coronavirus Vaccine Revenue Market Share by Type (2024-2033)
Table 11. North America Coronavirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 12. North America Coronavirus Vaccine Revenue by Type (2024-2033) & (US$ Million)
Table 13. Europe Coronavirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 14. Europe Coronavirus Vaccine Revenue by Type (2024-2033) & (US$ Million)
Table 15. Asia-Pacific Coronavirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 16. Asia-Pacific Coronavirus Vaccine Revenue by Type (2024-2033) & (US$ Million)
Table 17. Latin America Coronavirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 18. Latin America Coronavirus Vaccine Revenue by Type (2024-2033) & (US$ Million)
Table 19. Middle East and Africa Coronavirus Vaccine Revenue by Type (2018-2023) & (US$ Million)
Table 20. Middle East and Africa Coronavirus Vaccine Revenue by Type (2024-2033) & (US$ Million)
Table 21. Global Coronavirus Vaccine Market Size (US$ Million) by Application: 2018 VS 2023 VS 2033
Table 22. Global Coronavirus Vaccine Market Size by Application (2018-2023) & (US$ Million)
Table 23. Global Coronavirus Vaccine Revenue Market Share by Application (2018-2023)
Table 24. Global Coronavirus Vaccine Forecasted Market Size by Application (2024-2033) & (US$ Million)
Table 25. Global Coronavirus Vaccine Revenue Market Share by Application (2024-2033)
Table 26. North America Coronavirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 27. North America Coronavirus Vaccine Revenue by Application (2024-2033) & (US$ Million)
Table 28. Europe Coronavirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 29. Europe Coronavirus Vaccine Revenue by Application (2024-2033) & (US$ Million)
Table 30. Asia-Pacific Coronavirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 31. Asia-Pacific Coronavirus Vaccine Revenue by Application (2024-2033) & (US$ Million)
Table 32. Latin America Coronavirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 33. Latin America Coronavirus Vaccine Revenue by Application (2024-2033) & (US$ Million)
Table 34. Middle East and Africa Coronavirus Vaccine Revenue by Application (2018-2023) & (US$ Million)
Table 35. Middle East and Africa Coronavirus Vaccine Revenue by Application (2024-2033) & (US$ Million)
Table 36. Global Coronavirus Vaccine Revenue (US$ Million) by Players (2018-2023)
Table 37. Global Coronavirus Vaccine Revenue Market Share by Players (2018-2023)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Coronavirus Vaccine as of 2023)
Table 39. Date of Key Players Enter into Coronavirus Vaccine Market
Table 40. Global Coronavirus Vaccine Key Players Headquarters and Area Served
Table 41. Coronavirus Vaccine Product Solution and Service
Table 42. Global Coronavirus Vaccine Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Іnоvіо Рhаrmасеutісаlѕ Basic Information List
Table 45. Іnоvіо Рhаrmасеutісаlѕ Description and Business Overview
Table 46. Іnоvіо Рhаrmасеutісаlѕ Coronavirus Vaccine Products, Services and Solutions
Table 47. Revenue (US$ Million) in Coronavirus Vaccine Business of Іnоvіо Рhаrmасеutісаlѕ (2018-2023)
Table 48. Іnоvіо Рhаrmасеutісаlѕ Recent Developments
Table 49. Моdеrnа Basic Information List
Table 50. Моdеrnа Description and Business Overview
Table 51. Моdеrnа Coronavirus Vaccine Products, Services and Solutions
Table 52. Revenue (US$ Million) in Coronavirus Vaccine Business of Моdеrnа (2018-2023)
Table 53. Моdеrnа Recent Developments
Table 54. Nоvаvах Basic Information List
Table 55. Nоvаvах Description and Business Overview
Table 56. Nоvаvах Coronavirus Vaccine Products, Services and Solutions
Table 57. Revenue (US$ Million) in Coronavirus Vaccine Business of Nоvаvах (2018-2023)
Table 58. Nоvаvах Recent Developments
Table 59. Рrоtеіn Роtеntіаl Basic Information List
Table 60. Рrоtеіn Роtеntіаl Description and Business Overview
Table 61. Рrоtеіn Роtеntіаl Coronavirus Vaccine Products, Services and Solutions
Table 62. Revenue (US$ Million) in Coronavirus Vaccine Business of Рrоtеіn Роtеntіаl (2018-2023)
Table 63. Рrоtеіn Роtеntіаl Recent Developments
Table 64. АlрhаVах Basic Information List
Table 65. АlрhаVах Description and Business Overview
Table 66. АlрhаVах Coronavirus Vaccine Products, Services and Solutions
Table 67. Revenue (US$ Million) in Coronavirus Vaccine Business of АlрhаVах (2018-2023)
Table 68. АlрhаVах Recent Developments
Table 69. Ѕуnаіrgеn РLС Basic Information List
Table 70. Ѕуnаіrgеn РLС Description and Business Overview
Table 71. Ѕуnаіrgеn РLС Coronavirus Vaccine Products, Services and Solutions
Table 72. Revenue (US$ Million) in Coronavirus Vaccine Business of Ѕуnаіrgеn РLС (2018-2023)
Table 73. Ѕуnаіrgеn РLС Recent Developments
Table 74. NаnоVіrісіdеѕ Basic Information List
Table 75. NаnоVіrісіdеѕ Description and Business Overview
Table 76. NаnоVіrісіdеѕ Coronavirus Vaccine Products, Services and Solutions
Table 77. Revenue (US$ Million) in Coronavirus Vaccine Business of NаnоVіrісіdеѕ (2018-2023)
Table 78. NаnоVіrісіdеѕ Recent Developments
Table 79. GGеnеСurе Basic Information List
Table 80. GGеnеСurе Description and Business Overview
Table 81. GGеnеСurе Coronavirus Vaccine Products, Services and Solutions
Table 82. Revenue (US$ Million) in Coronavirus Vaccine Business of GGеnеСurе (2018-2023)
Table 83. GGеnеСurе Recent Developments
Table 84. North America Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 85. North America Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 86. Europe Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 87. Europe Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 88. Asia-Pacific Coronavirus Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 89. Asia-Pacific Coronavirus Vaccine Market Size by Region (2018-2023) & (US$ Million)
Table 90. Asia-Pacific Coronavirus Vaccine Market Size by Region (2024-2033) & (US$ Million)
Table 91. Asia-Pacific Coronavirus Vaccine Market Share by Region (2018-2023)
Table 92. Asia-Pacific Coronavirus Vaccine Market Share by Region (2024-2033)
Table 93. Latin America Coronavirus Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 94. Latin America Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 95. Latin America Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 96. Middle East & Africa Coronavirus Vaccine Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2023 VS 2033
Table 97. Middle East & Africa Coronavirus Vaccine Market Size by Country (2018-2023) & (US$ Million)
Table 98. Middle East & Africa Coronavirus Vaccine Market Size by Country (2024-2033) & (US$ Million)
Table 99. Coronavirus Vaccine Market Trends
Table 100. Coronavirus Vaccine Market Drivers
Table 101. Coronavirus Vaccine Market Challenges
Table 102. Coronavirus Vaccine Market Restraints
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Coronavirus Vaccine Market Size Year-over-Year 2018-2033 & (US$ Million)
Figure 2. Global Coronavirus Vaccine Market Size (US$ Million), 2018 VS 2023 VS 2033
Figure 3. Global Coronavirus Vaccine Market Share by Regions: 2023 VS 2033
Figure 4. Global Coronavirus Vaccine Forecasted Market Size Share by Region (2024-2033)
Figure 5. North America Coronavirus Vaccine Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 6. Europe Coronavirus Vaccine Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 7. Asia-Pacific Coronavirus Vaccine Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 8. Latin America Coronavirus Vaccine Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 9. Middle East & Africa Coronavirus Vaccine Market Size Growth Rate (2018-2033) & (US$ Million)
Figure 10. Product Picture of Coronavirus Inactivated Vaccine
Figure 11. Global Coronavirus Inactivated Vaccine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 12. Product Picture of Live Attenuated Coronavirus Vaccine
Figure 13. Global Live Attenuated Coronavirus Vaccine Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 14. Product Picture of Coronavirus Vaccine Based On S Protein
Figure 15. Global Coronavirus Vaccine Based On S Protein Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 16. Global Coronavirus Vaccine Market Size Share by Type: 2023 & 2033
Figure 17. North America Coronavirus Vaccine Revenue Market Share by Type (2018-2033)
Figure 18. Europe Coronavirus Vaccine Revenue Market Share by Type (2018-2033)
Figure 19. Asia-Pacific Coronavirus Vaccine Revenue Market Share by Type (2018-2033)
Figure 20. Latin America Coronavirus Vaccine Revenue Market Share by Type (2018-2033)
Figure 21. Middle East and Africa Coronavirus Vaccine Revenue Market Share by Type (2018-2033)
Figure 22. Hospital Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 23. Clinic Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 24. Research Institute Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 25. Other Market Size (US$ Million) & YoY Growth (2018-2033)
Figure 26. Global Coronavirus Vaccine Market Size Share by Application: 2023 & 2033
Figure 27. North America Coronavirus Vaccine Revenue Market Share by Application (2018-2033)
Figure 28. Europe Coronavirus Vaccine Revenue Market Share by Application (2018-2033)
Figure 29. Asia-Pacific Coronavirus Vaccine Revenue Market Share by Application (2018-2033)
Figure 30. Latin America Coronavirus Vaccine Revenue Market Share by Application (2018-2033)
Figure 31. Middle East and Africa Coronavirus Vaccine Revenue Market Share by Application (2018-2033)
Figure 32. Coronavirus Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2023
Figure 33. Global Top 5 and Top 10 Players Coronavirus Vaccine Market Share in 2023
Figure 34. North America Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 35. U.S. Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 36. Canada Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 37. Germany Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 38. France Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 39. U.K. Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 40. Italy Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 41. Russia Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 42. Nordic Countries Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 43. Asia-Pacific Coronavirus Vaccine Market Share by Region (2018-2033)
Figure 44. China Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 45. Japan Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 46. South Korea Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 47. Southeast Asia Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 48. India Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 49. Australia Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 50. Latin America Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 51. Mexico Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 52. Brazil Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 53. Middle East & Africa Coronavirus Vaccine Market Share by Country (2018-2033)
Figure 54. Turkey Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 55. Saudi Arabia Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 56. UAE Coronavirus Vaccine Market Size (2018-2033) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report